Peter Wutzler1, Markus Knuf, Johannes Liese. 1. Universitätsklinikum Jena, Institut für Virologie und Antivirale Therapie, Hans-Knöll-Strasse 2 (Beutenberg Campus), Jena, Germany. peter.wutzler@med.uni-jena.de
Abstract
INTRODUCTION: Experience with one-dose varicella vaccination of children in the USA has shown that with high immunization coverage a marked decline in morbidity and mortality occurs. However, about one quarter of the vaccinees may develop breakthrough varicella. Although breakthrough infections are usually mild, the patients are potentially contagious. METHODS: Selective literature search, review of congress papers, and evaluation of the consensus statement of an expert panel on the use of monovalent varicella vaccines. RESULTS: Recent studies on the causes, effects, and consequences of breakthrough varicella after one-dose vaccination show that varicella vaccine should be given in two doses at least four to six weeks apart to achieve effective, long-lasting protection against chickenpox. Breakthrough disease cannot always be prevented, but two-dose vaccination offers significantly better protection than a single dose. These findings were considered in the approval process for the measles-mumps-rubella-varicella combination vaccines, which are licensed only for use in a two-dose schedule. DISCUSSION: The authors recommend the general implementation of a two-dose schedule for single-antigen varicella vaccines, which will continue to be available.
INTRODUCTION: Experience with one-dose varicella vaccination of children in the USA has shown that with high immunization coverage a marked decline in morbidity and mortality occurs. However, about one quarter of the vaccinees may develop breakthrough varicella. Although breakthrough infections are usually mild, the patients are potentially contagious. METHODS: Selective literature search, review of congress papers, and evaluation of the consensus statement of an expert panel on the use of monovalent varicella vaccines. RESULTS: Recent studies on the causes, effects, and consequences of breakthrough varicella after one-dose vaccination show that varicella vaccine should be given in two doses at least four to six weeks apart to achieve effective, long-lasting protection against chickenpox. Breakthrough disease cannot always be prevented, but two-dose vaccination offers significantly better protection than a single dose. These findings were considered in the approval process for the measles-mumps-rubella-varicella combination vaccines, which are licensed only for use in a two-dose schedule. DISCUSSION: The authors recommend the general implementation of a two-dose schedule for single-antigen varicella vaccines, which will continue to be available.
Authors: Shu Li; Ivan S F Chan; Holly Matthews; Joseph F Heyse; Christina Y Chan; Barbara J Kuter; Karen M Kaplan; S J Rupert Vessey; Jerald C Sadoff Journal: Pediatr Infect Dis J Date: 2002-04 Impact factor: 2.129
Authors: David E Michalik; Sharon P Steinberg; Philip S Larussa; Kathryn M Edwards; Peter F Wright; Ann M Arvin; Haley A Gans; Anne A Gershon Journal: J Infect Dis Date: 2008-04-01 Impact factor: 5.226
Authors: Sandra S Chaves; Paul Gargiullo; John X Zhang; Rachel Civen; Dalya Guris; Laurene Mascola; Jane F Seward Journal: N Engl J Med Date: 2007-03-15 Impact factor: 91.245
Authors: Paolo Bonanni; Anne Gershon; Michael Gershon; Andrea Kulcsár; Vassiliki Papaevangelou; Bernard Rentier; Catherine Sadzot-Delvaux; Vytautas Usonis; Timo Vesikari; Catherine Weil-Olivier; Peter de Winter; Peter Wutzler Journal: Pediatr Infect Dis J Date: 2013-07 Impact factor: 2.129